Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Dec 27, 2024; 16(12): 3694-3702
Published online Dec 27, 2024. doi: 10.4240/wjgs.v16.i12.3694
Table 2 Surgical outcomes and pathological results before and after propensity score, n (%)
VariableBefore matching
After matching

E (n = 135)
L (n = 71)
P value
E (n = 59)
L (n = 59)
P value
Operation time (min)105.0 (75.0-166.5)70.0 (50.0-90.0)< 0.001120.0 (84.5-177.5)70.0 (50.0-100.0)< 0.001
Postoperative hospital stay (d)7.0 (5.0-8.0)7.0 (5.0-8.0)0.6597.0 (6.0-8.0)7.0 (5.0-8.0)0.478
Time to liquid diet (d)4.0 (3.0-5.0)5.0 (4.0-6.0)0.0084.0 (3.0-5.0)5.0 (4.0-6.0)0.046
Hospital cost (104 RMB)2.5 (2.1-3.8)2.6 (2.2-3.1)0.5782.6 (2.1-3.7)2.6 (2.2-3.1)0.469
Postoperative symptoms0.0800.040
No126 (93.3)61 (85.9)56 (94.9)49 (83.1)
Yes9 (6.7)10 (14.1)3 (5.1)10 (16.9)
Complications0.863> 0.999
Yes16 (11.9)9 (12.7)8 (13.6)8 (13.6)
No119 (88.1)62 (87.3)51 (86.4)51 (86.4)
Infection0.3930.378
Yes12 (8.9)9 (12.7)5 (8.5)8 (13.6)
No123 (91.1)62 (87.3)54 (91.5)51 (86.4)
Bleeding0.3510.242
Yes4 (3.0)0 (0.0)3 (5.1)0 (0.0)
No131 (97.0)71 (100.0)56 (94.9)59 (100.0)
Leakage0.345> 0.999
Yes0 (0.0)1 (1.4)0 (0.0)1 (1.7)
No135 (100.0)70 (98.6)59 (100.0)58 (98.3)
Complete resection< 0.001< 0.001
Yes107 (79.3)70 (98.6)43 (72.9)58 (98.3)
No28 (20.7)1 (1.4)16 (27.1)1 (1.7)
Mitotic index0.2000.262
<5/50 HPFs113 (83.7)52 (73.2)51 (86.4)45 (76.3)
5-10/50 HPFs17 (12.6)15 (21.1)7 (11.9)10 (16.9)
≥ 10/50 HPFs5 (3.7)4 (5.6)1 (1.7)4 (6.8)
National Institutes of Health risk classification

0.097

0.145

Low risk112 (83.0)50 (70.4)51 (86.4)43 (72.9)
Intermediate risk17 (12.6)14 (19.7)6 (10.2)9 (15.3)
High risk6 (4.4)7 (9.9)2 (3.4)7 (11.9)
Follow-up time (mo)51.1 (28.7-74.2)54.0 (34.8-92.4)0.17346.2 (27.1-71.4)54.40 (34.1-87.9)0.179
Recurrence> 0.9990.476
No132 (97.8)69 (97.2)59 (100.0)57 (96.6)
Yes3 (2.2)2 (2.8)0 (0.0)2 (3.4)
Death> 0.9990.611
No129 (95.6)68 (95.8) 58 (98.3)56 (94.9)
Yes6 (4.4)3 (4.2)1 (1.7)3 (5.1)